Moreover, to understand the clinical relevance of CIDEC/CCL2 axis in AAA progression, we analyzed the expression levels of CIDEC/FSP27 and CCL2 in a published human AAA study [28]. The gene discussed is CCL2; the disease is triple-A syndrome.